Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients (Q40214692)
Jump to navigation
Jump to search
scientific article published on 13 March 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients |
scientific article published on 13 March 2014 |
Statements
1 reference
Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients (English)
1 reference
J W Wilson
R R Razonable
Mayo Clinic Hematology/Oncology and Transplant Infectious Diseases Services
13 March 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference